Catalyst Wire Dossier Catalyst Wire Dossier

FP-01.1

· Immune Targeting Systems Ltd
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for FP-01.1, covering 2013-07-29 to 2016-10-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge [Phase 1, Phase 2]

See pricing